英文名称
N5-[4,5-Dihydro-5-oxo-4-[(2S,3R)-2,3,4-trihydroxybutyl]-1H-imidazol-2-yl]-L-ornithine
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
N5-[4,5-Dihydro-5-oxo-4-[(2S,3R)-2,3,4-trihydroxybutyl]-1H-imidazol-2-yl]-L-ornithine is an advanced glycation end-products that can be used to predict loss of renal function in American Indians with type 2 diabetes.